Found: 9
Select item for more details and to access through your institution.
Metabolic and Immune Activation Effects of Treatment Interruption in Chronic HIV-1 Infection: Implications for Cardiovascular Risk.
- Published in:
- PLoS ONE, 2008, v. 3, n. 4, p. 1, doi. 10.1371/journal.pone.0002021
- By:
- Publication type:
- Article
Abacavir/Lamivudine Versus Tenofovir DF/ Emtricitabine as Part of Combination Regimens for Initial Treatment of HIV: Final Results.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 8, p. 1191, doi. 10.1093/infdis/jir505
- By:
- Publication type:
- Article
Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. 12, p. 1791, doi. 10.1093/infdis/jir188
- By:
- Publication type:
- Article
Pharmacodynamics of daily subcutaneous recombinant human interleukin-3 in normal volunteers<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1995, v. 57, n. 1, p. 32, doi. 10.1016/0009-9236(95)90263-5
- By:
- Publication type:
- Article
Overcoming Health Literacy Barriers to Improve Asthma Inhaler Therapy Adherence.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A contiguous deletion syndrome of X-linked agammaglobulinemia and sensorineural deafness.
- Published in:
- Pediatric Allergy & Immunology, 2001, v. 12, n. 2, p. 107, doi. 10.1034/j.1399-3038.2001.0129999107.x
- By:
- Publication type:
- Article
Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1.
- Published in:
- Annals of Internal Medicine, 2011, v. 154, n. 7, p. 445, doi. 10.7326/0003-4819-154-7-201104050-00316
- By:
- Publication type:
- Article
Decreasing the Peril of Antimicrobial Resistance Through Enhanced Health Literacy in Outpatient Settings: An Underrecognized Approach to Advance Antimicrobial Stewardship.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s.
- Published in:
- Clinical Infectious Diseases, 2011, v. 53, n. 2, p. 185, doi. 10.1093/cid/cir324
- By:
- Publication type:
- Article